MedTrace Logo

tSCS in Children With Spina Bifida

NCT07615686 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-05-29

No results posted yet for this study

Summary

A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.

Conditions

  • Spina Bifida
  • Myelomeningocele

Interventions

DEVICE

Transcutaneous stimulator

an off the shelf TENS unit or Digitimer DS8R (using same parameters as TENS unit)

Sponsors & Collaborators

  • Bailey Petersen

    lead OTHER

Principal Investigators

  • Bailey Petersen, PhD · University of Pittsburgh

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-10
Primary Completion
2028-03-10
Completion
2029-03-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07615686 on ClinicalTrials.gov